InvestorsHub Logo
Followers 4
Posts 106
Boards Moderated 0
Alias Born 08/24/2020

Re: None

Saturday, 10/03/2020 10:22:24 PM

Saturday, October 03, 2020 10:22:24 PM

Post# of 198944

BioClonetics said that because of the similar structures of HIV and COVID-19 and the efficacy of its Clone 3 antibody in fighting HIV, the company has been asked by the National Science Foundation to submit a funding application for development of a COVID-19 antibody. The company currently has applications pending with the NSF and the National Institutes of Health.


https://www.bizjournals.com/dallas/inno/stories/news/2020/09/17/bioclonetics-immunotherapeutics-charles-cotropia.html
$enzc